Conference Description

August 13, 2005
Sheraton Chapel Hill
One Europa Drive
Chapel Hill, NC 27517
919-968-4900

Tell a friend about this conference
Download the brochure for this conference
See how attendees evaluated this conference

CME Credits 7.25*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this CME activity, the participant will be able to:

1. stratify patients with Acute Coronary Syndrome by risk and have a clearer understanding of conservative versus invasive treatment strategy with pharmacotherapy and catheter based protocols
2. more effectively manage heart failure and understand indications and implications of biventricular devices and cardiac defibrillators
3. understand the role of the incretin hormone glucagon-like peptide-1 (GLP-1) in normal physiology and in patients with type 2 diabetes and the role of medications known as "incretin mimetics" and "incretin enhancers" in the treatment of patients with type 2 diabetes
4. evaluate, stage and manage patients with chronic kidney disease
5. understand the importance of pulmonary function testing (spirometry) and utilize the results in the diagnosis and treatment of COPD
6. utilize the latest data to effectively treat patients with GERD and erosive esophagitis as well as those requiring the regular use of NSAIDS
7. distinguish Depression and Anxiety from Bipolar Disorder, and utilize effective treatments available

Agenda:

7:30-8:10		Continental Breakfast and Registration
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:20		Advances in the Diagnosis and Treatment of Acute Coronary Syndrome Alexandre Ferreira, MD
9:20-10:20		Integrating Advanced Heart Failure Management with the Use of Cardiac Devices: Role of the Primary Physician Juan Aranda, MD
10:20-10:40		Break/Vendor Area
10:40-11:40		Diabetes – Update on the Incretin Hormones Scott Joy, MD
11:40-12:40		Chronic Renal Disease Biff Palmer, MD
12:40-1:30		Lunch
1:30-2:30		Airways Obstruction: Many Faces, None Pretty Tom Ferro, MD
2:30-3:30		Differential Diagnosis and Treatment of Bipolar Disorder Michael Ostacher, MD
3:30-3:50		Break/Vendor Area
3:50-4:50		Acid Suppression 2005: From GERD to NSAIDS Ken Devault, MD
4:50-5:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Juan Aranda, MD
Associate Professor of Medicine
Division of Cardiovascular Medicine
University of Florida College of Medicine

Kenneth R. DeVault, MD
Professor of Medicine
Chair, Division of Gastroenterology and Hepatology
Mayo Clinic College of Medicine

Alexandre Ferreira, MD
Associate Professor of Clinical Medicine at
the University of Miami
Medical Director of Coronary Care Unit at
Jackson Memorial Hospital
Co-director of the Interventional Cardiology Training Program

Thomas Ferro, MD
Professor of Internal Medicine and Physiology in
the Pulmonary and Critical Care Division of the Medical College
of Virginia at Virginia Commonwealth University,
Medical Director of Pulmonary & Critical Care Research
McGuire VA Medical Center in Richmond, VA

Scott V. Joy, MD, CDE, FACP
Associate Clinical Professor of Medicine
Certified Diabetes Educator
Duke University Medical Center

Michael Ostacher, MD
Harvard Bipolar Research Program
Massachusetts General Hospital
Instructor, Harvard Medical School
Harvard Bipolar Research Program

Biff Palmer, MD
Professor of Internal Medicine
Nephrology Fellowship Program Director
UT Southwestern Medical Center
Dallas, Texas

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.25 Prescribed credit hours by the American Academy of Family Physicians.

This program was supported through educational grants from the following companies: Amylin, Boehringer Ingelheim, Merck, Novartis, sanofi-aventis, Takeda.